Skip to content

Synergic Control of Posture in Peripheral Neuropathies' Patients

Synergic Control of Posture in Peripheral Neuropathies' Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05088681
Acronym
NEUPER
Enrollment
26
Registered
2021-10-22
Start date
2021-09-03
Completion date
2024-04-30
Last updated
2024-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Neuropathies

Brief summary

This is a multicenter observational study aimed to characterize multi-muscle synergy organization in relation to postural stability in individuals with Peripheral Neuropathies (PN) compared to healthy age-matched subjects and to assess the effectiveness of a rehabilitation program driven by multi-muscle synergy organization.

Detailed description

This is a multicenter observational study of peripheral neuropathies patients aiming at characterizing multi-muscle synergy and at assessing the effectiveness of a rehabilitation program driven by multi-muscle synergy organization. The study can be divided in two phases: Phase 1 will included peripheral neuropathies patients and healthy age-matched subjects. Peripheral neuropathies patients will be assessed with: * Neurological assessment formalized via Total Neuropathy Score-clinical version (TNSc©) * Nerve conduction studies * Impact of PN on patients' quality of life using Short Form Health Survey 36 (SF-36) * Functional status using Functional Independence Measure (FIM) Peripheral neuropathies patients and healthy age-matched subjects will receive a postural evaluation recording during three different postural tasks (quiet standing, voluntary sway and shoulder flexion): * centre of pressure (COP) displacement of force platform; * surface muscle activation using electromyography (EMG) of 13 muscle on the right side of the body (tibialis anterior, soleus,gastrocnemius lateralis-medialis, biceps femoris, semitendinosus, rectus femoris, vastus lateralis and medialis, tensor fasciae latae, lumbar and thoracic erector spinae and rectus abdominis). Phase 2 will included only peripheral neuropathies patients. Participants will be assessed at baseline, after a 20 session 2-3/w program of physical therapy and at a follow up of 3 months. The evaluations of the first phase will be implemented with evaluation of mobility and balance using Six Minute Walking Test (6MWT), Mini Balance Evaluation System Test (MiniBESTest) and Timed Up and Go test (TUG).

Interventions

OTHERRehabilitation program

The exercise intervention will consist of an individualized prescription of resistance training, balance training and cardiovascular exercises delivered for 20 session, one-hour, two/three times per week.

Sponsors

University of Milano Bicocca
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Subject suffering from peripheral neuropathy with a TNSc© score more than 4 * male and female subjects who are 18 years of age or older

Exclusion criteria

* orthopedic or neurologic comorbidities that can influence postural control A control group of healthy subjects with the same demographic features of peripheral neuropathy patients wil be also included.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of mobilityAt baseline, after the 20th session of the rehabilitation program, follow up at 3 monthsEvaluation of mobility using Six Minute Walking Test (6MWT). The 6MWT assesses distance walked over six minutes as a sub-maximal test of endurance/aerobic capacity.
Evaluation of multi-muscle synergy organization using Synergy Index (SI)At baseline, after the 20th session of the rehabilitation program, follow up at 3 monthsMulti-muscle Synergy Index (SI) are new measurements of postural stability and a proxy of multi-muscle coordination. Synergy has been defined as a neural organization of a large set of effectors (e.g., muscles) providing stability of salient performance variables (e.g., center of pressure, COP). Within this framework, SI has been introduced, reflecting the relative amount of inter-trial variance that does not affect a performance variable.
Evaluation of change in Anticipatory Synergy Adjustments (ASA)At baseline, after the 20th session of the rehabilitation program, follow up at 3 monthsASAs represent changes in an index of a multi-muscle synergy stabilizing the coordinate of the center of pressure (COP). Such changes may be seen in young, healthy persons about 200-300 ms prior to the action initiation.
Evaluation of balanceAt baseline, after the 20th session of the rehabilitation program, follow up at 3 monthsEvaluation of balance using Mini Balance Evaluation System Test (MiniBESTest). Each item is scored on a 0-4 scale; the scores are summed to obtain a total score of 28. The item are divided in four sessions: anticipatory, reactive postural control, sensory orientation, dynamic gait.

Secondary

MeasureTime frameDescription
Severity of chemotherapy induced-peripheral neuropathyAt baseline, after the 20th session of the rehabilitation program, follow up at 3 monthsTotal Neuropathy Score-clinical version (TNSc©)
Evaluation of change in electromyography (EMG) parametersAt baseline, after the 20th session of the rehabilitation program, follow up at 3 monthsEvaluation of sensory conduction velocity of ulnar, radial and sural nerves.
Impact of PN on patients' quality of lifeAt baseline, after the 20th session of the rehabilitation program, follow up at 3 monthsEvaluation of quality of life using the Short Form Health Survey 36 (SF-36). It is a self-report measure of functional health and well-being. The SF-36 questionnaire consists of eight scales yielding two summary measures: physical and mental health. The physical health measure includes four scales of physical functioning (10 items), role-physical (4 items), bodily pain (2 items), and general health (5 items). The mental health measure is composed of vitality (4 items), social functioning (2 items), role-emotional (3 items), and mental health (5 items).
Evaluation of change in level of disabilityAt baseline, after the 20th session of the rehabilitation program, follow up at 3 monthsEvaluation of level of disability using Functional Independence Measure (FIM). It is an 18-item, seven-level, ordinal scale intended to be sensitive to changes over the course of a comprehensive inpatient medical rehabilitation program.It includes measures of independence for self-care, including sphincter control, transfers, locomotion, communication, and social cognition.

Countries

Italy

Contacts

Primary ContactMiryam Mazzucchelli, MD
m.mazzucchelli@campus.unimib.it+39 0362 986201

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026